UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma

International journal of cancer, 2018-09, Vol.143 (5), p.1188-1201

2018

Link zum Volltext

Verfügbarkeit prüfen

Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1

Oncogene, 2022-04, Vol.41 (18), p.2638-2650

2022

Link zum Volltext

Verfügbarkeit prüfen

Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors

Molecular therapy. Nucleic acids, 2023-06, Vol.32, p.758-772

2023

Link zum Volltext

Verfügbarkeit prüfen

Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas

Scientific reports, 2019-03, Vol.9 (1), p.3816-3816, Article 3816

2019

Link zum Volltext

Verfügbarkeit prüfen

Requirement of plasminogen binding to its cell-surface receptor α-enolase for efficient regeneration of normal and dystrophic skeletal muscle

PloS one, 2012-12, Vol.7 (12), p.e50477-e50477

2012

Link zum Volltext

Verfügbarkeit prüfen

uPA deficiency exacerbates muscular dystrophy in MDX mice

The Journal of cell biology, 2007-09, Vol.178 (6), p.1039-1051

2007

Link zum Volltext

Verfügbarkeit prüfen

Harnessing subcellular-resolved organ distribution of cationic copolymer-functionalized fluorescent nanodiamonds for optimal delivery of active siRNA to a xenografted tumor in mice

Nanoscale, 2021-05, Vol.13 (2), p.928-9292

2021

Link zum Volltext

Verfügbarkeit prüfen

LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity

Cancer letters, 2020-04, Vol.474, p.1-14

2020

Link zum Volltext

Verfügbarkeit prüfen

The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy

Frontiers in oncology, 2015-04, Vol.5, p.82-82

2015

Link zum Volltext

Verfügbarkeit prüfen

Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway

Oncotarget, 2016-08, Vol.7 (35), p.56889-56903

2016

Link zum Volltext

Verfügbarkeit prüfen

Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo

Blood, 2002-04, Vol.99 (8), p.2835-2844

2002

Link zum Volltext

Verfügbarkeit prüfen

uPA deficiency exacerbates muscular dystrophy in MDX mice

The Journal of cell biology, 2007-10, Vol.179 (1), p.165-165

2007

Link zum Volltext

Verfügbarkeit prüfen

Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth

Oncotarget, 2014-10, Vol.5 (20), p.9744-9755

2014

Link zum Volltext

Verfügbarkeit prüfen

Metastasis Assessment in Ewing Sarcoma Using Orthotopic Xenografts

Methods in molecular biology (Clifton, N.J.), 2021, Vol.2226, p.201

2021

Link zum Volltext

Verfügbarkeit prüfen

"(Not) all (dead) things share the same breath": identification of cell death mechanisms in anticancer therapy

Cancer research (Chicago, Ill.), 2015-03, Vol.75 (6), p.913-917

2015

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α‐Enolase

American journal of hematology, 2003-04, Vol.72 (4), p.234-242

2003

Link zum Volltext

Verfügbarkeit prüfen

Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis

Thrombosis and haemostasis, 2003-10, Vol.90 (4), p.724

2003

Link zum Volltext

Verfügbarkeit prüfen

Cell Death Identification in Anticancer Therapy-Response

Cancer research (Chicago, Ill.), 2015-09, Vol.75 (17), p.3682-3682

2015

Link zum Volltext

Verfügbarkeit prüfen

Plasminogen activator inhibitor type‐1 inhibits insulin signaling by competing with αvβ3 integrin for vitronectin binding

European journal of biochemistry, 2003-03, Vol.270 (5), p.814-821

2003

Link zum Volltext

Verfügbarkeit prüfen

Requirement of Plasminogen Binding to Its Cell-Surface Receptor [alpha]-Enolase for Efficient Regeneration of Normal and Dystrophic Skeletal Muscle

PloS one, 2012-12, Vol.7 (12), p.e50477

2012

Link zum Volltext

Verfügbarkeit prüfen

Bcl-x L inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas

Scientific reports, 2019-12, Vol.9 (1), p.3816

2019

Link zum Volltext

Verfügbarkeit prüfen

Harnessing subcellular-resolved organ distribution of cationic copolymer-functionalized fluorescent nanodiamonds for optimal delivery of therapeutic siRNA to a xenografted tumor in mice

Nanoscale, 2021-04, Vol.13 (20), p.9280-9292

2021

Link zum Volltext

Verfügbarkeit prüfen

Combination of CDK and Bcl-2 inhibitors in the treatment of soft-tissue sarcomas

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.11582-11582

2018

Link zum Volltext

Verfügbarkeit prüfen

α-Enolase, a multifunctional protein: its role on pathophysiological situations

Journal of biomedicine & biotechnology, 2012-01, Vol.2012, p.156795

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma

Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1

Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors

Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas

Requirement of plasminogen binding to its cell-surface receptor α-enolase for efficient regeneration of normal and dystrophic skeletal muscle

uPA deficiency exacerbates muscular dystrophy in MDX mice

Harnessing subcellular-resolved organ distribution of cationic copolymer-functionalized fluorescent nanodiamonds for optimal delivery of active siRNA to a xenografted tumor in mice

LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity

The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy

Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway

Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo

DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1

uPA deficiency exacerbates muscular dystrophy in MDX mice

Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth

Metastasis Assessment in Ewing Sarcoma Using Orthotopic Xenografts

"(Not) all (dead) things share the same breath": identification of cell death mechanisms in anticancer therapy

Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α‐Enolase

Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis

Cell Death Identification in Anticancer Therapy-Response

Plasminogen activator inhibitor type‐1 inhibits insulin signaling by competing with αvβ3 integrin for vitronectin binding

Requirement of Plasminogen Binding to Its Cell-Surface Receptor [alpha]-Enolase for Efficient Regeneration of Normal and Dystrophic Skeletal Muscle

Bcl-x L inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas

Harnessing subcellular-resolved organ distribution of cationic copolymer-functionalized fluorescent nanodiamonds for optimal delivery of therapeutic siRNA to a xenografted tumor in mice

Combination of CDK and Bcl-2 inhibitors in the treatment of soft-tissue sarcomas

α-Enolase, a multifunctional protein: its role on pathophysiological situations

Suchergebnisse filtern